Učitavanje...

Severe cholestasis due to adalimumab in a Crohn’s disease patient

Elevation of liver biochemistry has been reported with anti-tumor necrosis factor agents, but overt liver failure rarely reported. Autoimmune hepatitis has been more commonly reported with infliximab than adalimumab (ADA). Our case, however, describes the first reported case of ADA-associated severe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kim, Edward, Bressler, Brian, Schaeffer, David F, Yoshida, Eric M
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Co., Limited 2013
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3812463/
https://ncbi.nlm.nih.gov/pubmed/24179620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v5.i10.592
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!